Gansu Zongxing Mushroom Technology Co., Ltd.

Zongxing Mushroom is the most profitable company on this page relative to its size. It grows only two crops, sells almost nothing that is not a mushroom, and still earned a solid profit in a year when a larger Chinese rival was climbing out of a heavy loss. It ranks fifth on that combination of focus and margins rather than on absolute scale.

Industry Position

Sixteen production bases give the company annual capacity above 360,000 tonnes, split between two cultivation systems: enoki in bottles at more than 700 tonnes a day, and agaricus button mushrooms on compost at roughly 300 tonnes a day. Running both technologies is unusual, and it is the main reason the group is not dependent on a single price cycle the way single-crop growers are. Button mushrooms also open the retail and processing trade that enoki does not reach, so the two lines are sold through overlapping but distinct channels.

Revenue reached RMB 2.098 billion in 2025, about US$295 million, up 8.43 per cent, and edible mushrooms account for about 99 per cent of sales, the highest category purity in this ranking. Net profit attributable to shareholders was RMB 335 million. First-half 2026 revenue of RMB 1.085 billion suggests the pattern held, and about 3,800 people are employed across the group. Because the company is listed on the main board of the Shenzhen Stock Exchange, these figures come from public filings rather than private estimates, which is not the case for several larger competitors on this page.

Competitive Advantages

The dual-crop structure is the first advantage. Enoki and button mushrooms use different substrates, different rooms and different end markets, so when one category weakens the other can carry more of the load; competitors concentrated in enoki alone experienced the opposite in the years when that market was oversupplied nationally.

The second is vertical control of the biology. Spawn breeding and liquid fermentation are handled internally, and substrate is formulated by the company rather than bought, which puts the two steps most likely to destroy a crop cycle under its own quality systems. That combination, with high capacity utilisation, is what produced RMB 335 million of profit on a revenue base where larger rivals were barely breaking even.

Strategic Expansion

Growth is being pursued through capacity rather than acquisition. New production lines are under construction across the existing provincial network, which spreads volume closer to demand and reduces refrigerated transport distances, and the company keeps adding to a base count that already spans Gansu, Shaanxi, Shandong, Jiangsu, Sichuan and Anhui.

The second direction is international. A joint venture project in Poland is the company's first production outside China, and it is a test of whether a model built on Chinese provincial economics, cheap land, controlled rooms and local demand, can be repeated in a European cost environment where labour and energy are far more expensive.

Risks & Outlook

Execution of the capital programme is the nearer risk. Construction schedules for some new production lines have been adjusted slightly by local planning requirements, so capacity that has been budgeted and announced can arrive later than intended, and a delay while depreciation and staffing are already in place works directly against the 2025 margin.

The other exposure is price. Both of the company's crops are commodities traded on national supply and demand, and with about 99 per cent of revenue in edible mushrooms there is no second business to cushion a weak year. Gansu Zongxing Mushroom Technology is not a Fortune Global 500 company. On this page's weightings the purity, the margin and the two-crop platform justify fifth place. VerityRank Score of 85/100.